3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
43
Leukemia
17
Recurrence
7
Lymphoma
7
Burkitt Lymphoma
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Biphenotypic, Acute
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, T-Cell
2
Leukemia, Myeloid, Acute
2
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, B-Cell
1
Immunoproliferative Disorders
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Down Syndrome
1
Blast Crisis
1
Interventions
fludarabine phosphate
19
Peripheral Blood Stem Cell Transplantation
15
Cyclophosphamide
15
Whole-Body Irradiation
14
Tacrolimus
13
Mycophenolic Acid
13
Busulfan
12
Antilymphocyte Serum
11
Rituximab
9
Etoposide
7
Methotrexate
6
Cyclosporine
6
Melphalan
5
thymoglobulin
4
Flow Cytometry
4
Carboplatin
4
Therapeutics
3
Radiotherapy
3
Lenalidomide
3
In Situ Hybridization, Fluorescence
3
Immunohistochemistry
3
Gene Expression Profiling
3
Filgrastim
3
Everolimus
3
Amplified Fragment Length Polymorphism Analysis
3
Alemtuzumab
3
fludarabine
2
Vorinostat
2
Vincristine
2
Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Extranodal NK-T-Cell
×
pegaspargase
×
Clear all
No trials found.